Search results
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
ABC News· 3 hours agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 6 hours agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 3 hours agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 4 hours agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of...
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
Barrons.com· 3 hours agoThe results could to upend the flu market if they withstand scrutiny from regulators. More than half...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 4 hours agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 4 hours agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of Merck's ...
Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
FierceBiotech· 3 hours agoModerna’s combo flu and COVID-19 vaccine zipped through a late-stage trial this winter, and the results are showing a higher immune response than licensed ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoRepresentatives from Moderna, Pfizer-BioNtech, and Novavax presented data about the protection...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 7 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
